Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
It is a fine powder composed of zinc (oxide or carbonate) and a small amount of iron oxide.
Used, without evidence of its efficacy, as a skin antipruritic.
Authorized use in young infants.
Topical application.
Since the last update we have not found any published data on its excretion in breast milk.
The small dose and poor plasma uptake of most topical dermatological preparations make it very unlikely that significant amounts will pass into breast milk.
Do not apply on the chest to prevent the infant from ingesting it; if necessary, apply after breastfeeding and clean well with water before the next feed.
List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002).